Whether early-stage (N0 neck) oral cancer patients received primary tumor resection without neck dissection benefit from immune checkpoint therapy

Detalles Bibliográficos
Autores principales: Liu, Wei, Shen, Xuemin, Shi, Linjun, He, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651285/
https://www.ncbi.nlm.nih.gov/pubmed/37994732
http://dx.doi.org/10.1097/JS9.0000000000000649
_version_ 1785147620325326848
author Liu, Wei
Shen, Xuemin
Shi, Linjun
He, Yue
author_facet Liu, Wei
Shen, Xuemin
Shi, Linjun
He, Yue
author_sort Liu, Wei
collection PubMed
description
format Online
Article
Text
id pubmed-10651285
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106512852023-11-15 Whether early-stage (N0 neck) oral cancer patients received primary tumor resection without neck dissection benefit from immune checkpoint therapy Liu, Wei Shen, Xuemin Shi, Linjun He, Yue Int J Surg Correspondence Lippincott Williams & Wilkins 2023-09-02 /pmc/articles/PMC10651285/ /pubmed/37994732 http://dx.doi.org/10.1097/JS9.0000000000000649 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (https://creativecommons.org/licenses/by-nc/4.0/) (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Correspondence
Liu, Wei
Shen, Xuemin
Shi, Linjun
He, Yue
Whether early-stage (N0 neck) oral cancer patients received primary tumor resection without neck dissection benefit from immune checkpoint therapy
title Whether early-stage (N0 neck) oral cancer patients received primary tumor resection without neck dissection benefit from immune checkpoint therapy
title_full Whether early-stage (N0 neck) oral cancer patients received primary tumor resection without neck dissection benefit from immune checkpoint therapy
title_fullStr Whether early-stage (N0 neck) oral cancer patients received primary tumor resection without neck dissection benefit from immune checkpoint therapy
title_full_unstemmed Whether early-stage (N0 neck) oral cancer patients received primary tumor resection without neck dissection benefit from immune checkpoint therapy
title_short Whether early-stage (N0 neck) oral cancer patients received primary tumor resection without neck dissection benefit from immune checkpoint therapy
title_sort whether early-stage (n0 neck) oral cancer patients received primary tumor resection without neck dissection benefit from immune checkpoint therapy
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651285/
https://www.ncbi.nlm.nih.gov/pubmed/37994732
http://dx.doi.org/10.1097/JS9.0000000000000649
work_keys_str_mv AT liuwei whetherearlystagen0neckoralcancerpatientsreceivedprimarytumorresectionwithoutneckdissectionbenefitfromimmunecheckpointtherapy
AT shenxuemin whetherearlystagen0neckoralcancerpatientsreceivedprimarytumorresectionwithoutneckdissectionbenefitfromimmunecheckpointtherapy
AT shilinjun whetherearlystagen0neckoralcancerpatientsreceivedprimarytumorresectionwithoutneckdissectionbenefitfromimmunecheckpointtherapy
AT heyue whetherearlystagen0neckoralcancerpatientsreceivedprimarytumorresectionwithoutneckdissectionbenefitfromimmunecheckpointtherapy

Ejemplares similares